At 8.2x earnings and 1.4x book, CIG screens statistically cheap, but the story gets murkier when you look forward: a 15.7 Forward P/E against a missing PEG and an Altman Z-Score of 1.7 signals balance sheet fragility and uncertain growth durability. The market is clearly discounting something, and the spike from 8.2x trailing to 15.7x forward suggests earnings compression ahead rather than expansion. A Piotroski F-Score of 5 and ROE of 7.60% reinforce the view of a middling-quality utility rather than a compounding machine. This is not a pristine balance sheet story, and the valuation discount is at least partially justified by financial risk and soft forward expectations.
⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.